openPR Logo
Press release

Balantidiasis Market Gains Momentum with a Striking CAGR of 2.1% by 2023

12-04-2017 12:17 PM CET | Health & Medicine

Press release from: Market Research Future

Balantidiasis Market Gains Momentum with a Striking CAGR of 2.1%

The global balantidiasis market is expected to grow at a CAGR of 2.1% during the forecast period.

Balantidiasis, also known as Balantidium coli infection, is a disease caused by intestinal protozoan parasite Balantidium coli. Being transmitted through the fecal-oral route, a person acquires the disease by ingesting infective cysts from food and water contaminated by feces. The global Balantidiasis Market is growing steadily and is expected to continue its growth during the forecast period.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/4725 .

The disease mainly affects large intestine. Diarrhea, weight loss, dysentery, abdominal pain, nausea, and vomiting are common symptoms for balantidiasis. The diseases is found to be prevalent in the rural areas of the developed and developing countries due to the contamination of water by the fecal matter of pigs or humans. The best remedy for the prevention of the disease are maintaining proper conditions for clean and safe drinking water. Antibiotics are most widely used for the treatment of balantidiasis.

Rising prevalence of gastrointestinal disorders, increasing number of patients and availability of treatment of balantidiasis drives the growth of the market. Additionally, the lack of hygiene and sanitation in the rural areas of developing countries is one of the many factors which affect the spread of this disease. Furthermore, rising awareness about the diseases transmitted through fecal-oral route influences the market growth. Competition among existing market players restrict the entry of new players.

Top Key Players of this Market:

Some of the key players in this market are Pfizer (U.S.), Abbott (U.S.), GlaxoSmithKline plc. (U.K), BD (U.S.), Sandoz International GmbH (Germany), Amneal Pharmaceuticals LLC. (U.S.), Akorn, Inc. (U.S.), and PharmaDerm, a division of Fougera Pharmaceuticals Inc. (U.S.).

Regional Analysis of the Global Balantidiasis Market:

The Balantidiasis Industry is found to be steady in Americas. The disease is less prevalent in North America due to high quality standards, negligible number of cases, and hygienic environment. Furthermore, emphasis on healthy life style and prevention of communicable diseases also influence the growth of the market. The prevalence of the disease is found to the higher rural South America than North American countries.

In Europe, the prevalence of balantidiasis is found to be low. Rising importance of hygienic food products and water, rigorous quality checks, rising expenditure on healthcare, and availability of funds boost the growth of the market.

In Asia Pacific, the prevalence of balantidiasis is found increasing steadily as a result of increasing prevalence of colitis, chronic diarrhea, and, deep intestinal ulcerations and poor hygienic conditions in developing countries. The infection is found to be sub clinical leading to the development of diarrhea leading to the perforation of colon. Furthermore, poor healthcare system in developing countries boost the market growth. Furthermore, the burden of gastrointestinal diseases is attributed to an increase in age, high prevalence of H pylori and lifestyle changes with risk factors such as smoking and obesity. According to the data from GLOBOCAN, in 2012, the age-standardized rate (ASR) of incidence for Asia Pacific was 15.8 and mortality was 11.7 per 100,000. According to World Health Organization (WHO), the geriatric population in China in the year 2013 was 22.6 million which is expected to show a massive growth to 90.4 million in 2050.

Apply for Discount @ https://www.marketresearchfuture.com/check-discount/4725 .

The Middle East & African region has high prevalence of balantidiasis. The infection is mainly acquired due to ingestion of food and water contaminated by cysts. Furthermore, gastrointestinal diseases are a major cause of disability in the Middle East & Africa. In Africa, the market for balantidiasis is driven by rising demand for primary care services and improving healthcare system.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Balantidiasis Market Gains Momentum with a Striking CAGR of 2.1% by 2023 here

News-ID: 843524 • Views:

More Releases from Market Research Future

Navigating Schizophrenia Care Market Expected to Expand to $8.06 Billion by 2030 | Johnson & Johnson, AstraZeneca, Eli Lilly, Alkermes
Navigating Schizophrenia Care Market Expected to Expand to $8.06 Billion by 2030 …
Schizophrenia Market Overview - The Schizophrenia Market Size was assessed at USD 5.5 billion in 2022 and is expected to expand from USD 5.76 billion in 2023 to USD 8.06 billion by 2030, with a compound annual growth rate (CAGR) of 4.9% during the forecast period (2023- 2030). The schizophrenia market is a significant segment within the pharmaceutical and mental healthcare industries, focused on addressing the complex needs of individuals living with
Revolutionizing Healing: Skin Graft Market Set to Grow at 7.01% CAGR, Reaching $7.36 Billion by 2032
Revolutionizing Healing: Skin Graft Market Set to Grow at 7.01% CAGR, Reaching $ …
Skin Graft Market Overview - In 2022, the skin graft market was estimated at USD 4.00 billion. The skin graft market is expected to increase from USD 4.28 billion in 2023 to USD 7.36 billion by 2032, with a compound annual growth rate (CAGR) of 7.01% over the forecast period (2023-2032). The skin graft market plays a crucial role in the field of dermatology and wound care, providing solutions for patients with
Medical Suction Device Market Size to Exceed USD 1.80 billion by 2032, with a Robust CAGR of 4.8%
Medical Suction Device Market Size to Exceed USD 1.80 billion by 2032, with a Ro …
Medical Suction Device Market Overview - The Medical Suction Device Market was valued at USD 0.92 billion in 2021. The Medical Suction Device Market is expected to increase from USD 0.96 billion in 2022 to USD 1.80 billion by 2032, with a compound yearly growth rate (CAGR) of 4.8% over the forecast period (2023-2032). The medical suction device market plays a vital role in healthcare settings by providing efficient suction for various
Agriculture Phosphate Fertilizer Market Poised for Growth Despite Sustainability Concerns
Agriculture Phosphate Fertilizer Market Poised for Growth Despite Sustainability …
Phosphate fertilizers Market Outlook Phosphate fertilizers are the cornerstone of modern agriculture, providing crops with the essential nutrient phosphorus (P) needed for healthy growth and development. As the global population continues to rise, so does the demand for food, driving the phosphate fertilizer market towards significant growth. According to a report by Market Research Future (MRFR), the market is expected to reach a value of USD 104.02 billion by 2032, with

All 5 Releases


More Releases for Balantidiasis

Balantidiasis Market 2019 Analysis by Treatment, Diagnosis and Research Advancem …
Market – Overview Balantidiasis is a disease caused by the bacterium Balantidium coli which mainly affects the large intestine. The disease spreads through fecal-oral route due to the contamination of food and water by the feces of pig or human. Improper sanitary conditions and unsafe drinking water are important aspects for the spread of the diseases. The global balantidiasis market is expected to grow at a CAGR of 2.1% during the forecast
Balantidiasis Market Research and Development Strategy 2019 by Leading Industry …
A Broad Analysis of the "Worldwide Chondrosarcoma market “methodology of the leading organizations in the exactness of import/export utilization, market activity figures, cost, value, revenue and gross edges. Market Synopsis of the Global Balantidiasis Market Balantidiasis is a disease caused by the bacterium Balantidium coli which mainly affects the large intestine. The disease spreads through fecal-oral route due to the contamination of food and water by the feces of pig or human.
Balantidiasis Market Import | Export Outlook and Global Foresight 2023
Report Description This report analyzes the global balantidiasis market by diagnosis (physical examination, stool examination, sigmoidoscopy, biopsy), by treatment (antibiotics, appendectomy), by end user (hospitals, clinics, diagnostic centers); it also studies the top manufacturers in the market. The global balantidiasis market is projected to grow at a CAGR of around 2.1% during the forecast period. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3403768-balantidiasis-market-research-report-global-forecast-till-2023 The major players in global balantidiasis market include: • Pfizer (U.S.) • Abbott (U.S.) • GlaxoSmithKline
Balantidiasis Indsutry Overview 2018 - Rising Prevalence of Communicable Disease …
Market Highlights: Balantidiasis is a disease caused by the bacterium Balantidium coli which mainly affects the large intestine. The disease spreads through fecal-oral route due to the contamination of food and water by the feces of pig or human. Improper sanitary conditions and unsafe drinking water are important aspects for the spread of the diseases. The market is driven by the increasing prevalence of communicable diseases in rural areas for developing countries.
Balantidiasis Market Research Segmented By Diagnosis, Treatment, End Users and G …
Global Balantidiasis Market growing at a CAGR of 3.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Market Definition: Global Balantidiasis Market Balantidiasis also called as Balantidium coli infection, is a disease infected due to intestinal protozoan parasite Balantidium coli. The parasite enters through the fecal-oral
Balantidiasis Market 2018 - Key Vendors are Pfizer (U.S.), Abbott (U.S.), GlaxoS …
Balantidiasis Market is expected to grow at a CAGR of 2.1% during the forecast period. The global balantidiasis market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, the market is segmented into stool examination, sigmoidoscopy, biopsy, and others. On the basis of treatment, the market is segmented into antibiotics, appendectomy, and others. Antibiotics segment is further divided into tetracycline, metronidazole, and others.